| Comparative effectiveness research priorities: Identifying critical gaps in evidence for clinical and health policy decision making / | Chalkidou, Kalipso. et al | 241-248 | 2009.07.27 | - | |
| The process of updating the National List of Health Services in Israel: Is it legitimate? Is it fair? / | Greenberg, Dan ;, Siebzehner, Miriam I. ;, Pliskin, Joseph S. I. ; | 255-261 | 2009.07.27 | - | |
| Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England / | Dietrich, Eva Susanne | 262-271 | 2009.07.27 | - | |
| Perspectives on the National Institute for Health and Clinical Excellence's recommendations to use health technologies only in research / | Dhalla, Irfan A. et al | 272-280 | 2009.07.27 | - | |
| Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: Comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden / | Schwarzer, Ruth ;, Siebert, Uwe | 305-314 | 2009.07.27 | - | |
| Surrogate outcomes in health technology assessment: An international comparison / | Garrido, Marcial Velasco ;, Mangiapane, Sandra | 315-322 | 2009.07.27 | - | |
| A cost-effectiveness analysis of a community-based diabetes prevention program in Sweden / | Johansson, Pia. et al | 350-358 | 2009.07.27 | - | |
| Horizon scanning of new and emerging medical technology in Australia: Its relevance to Medical Services Advisory Committee health technology assessments and public funding / | O'Malley, Sue P. ;, Jordan, Ernest | 374-382 | 2009.07.27 | - | |
